Acta Med. 2005, 48: 81-86

A Comparison of the Potency of the Oxime HLö-7 and Currently Used Oximes (HI-6, Pralidoxime, Obidoxime) to Reactivate Nerve Agent-Inhibited Rat Brain Acetylcholinesterase by in vitro Methods

Kamil Kuča, Jiří Cabal, Jiří Kassa, Daniel Jun, Martina Hrabinová

University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Toxicology, Hradec Králové, Czech Republic

Received December 1, 2004
Accepted May 1, 2005


1. Bajgar J, Fusek J, Vachek J. Treatment and prophylaxis against nerve agent poisoning. ASA Newslett 1994; 94–4:10–1.
2. Cabal J, Kuča K, Kassa J. Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Pharmacol Toxicol 2004; 95:81–6. <>
3. Dawson RM. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994; 14:317–31. <>
4. Eto M. Organophosphorus pesticides: organic and biological chemistry. Cleveland: CRC Press Inc., 1976:342.
5. Inns RH, Leadbeater L. The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea pig. J Pharm Pharmacol 1983; 35:427–33. <>
6. Jokanovic M., Maksimovic M, Kilibarda V, Jovanovic D, Savic D. Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol Lett 1996; 85:35–9. <>
7. Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol–Clin Toxicol 2002; 40:803–16. <>
8. Kassa J, Cabal J. A comparison of the efficacy of a new asymmetric bispyridinium oximes BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 1999; 132:111–8. <>
9. Kassa J, Cabal J. A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol Toxicol 1999; 84:41–5. <>
10. Koplovitz I, Stewart JR. A comparison of the efficacy of HI-6 and 2–PAM against soman, sarin and VX in the rabbit. Toxicol Lett 1995; 70:269–79. <>
11. Kuča K, Kassa J. A comparison of the ability of a new bispyridinium oxime – 1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium) butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J Enzyme Inhib Med Chem 2003; 18:529–35. <>
12. Kuča K, Kassa J. Oximes-induced reactivation of rat brain acetylcholinesterase inhibited by VX agent. Hum Exp Toxicol 2004; 23:167–71. <>
13. Kuča K, Patočka J, Cabal J. Reactivation of organophosphate inhibited acetylcholinesterase activity by α,ω-bis-(4-hydroxyiminomethylpyridinium) alkanes in vitro. J Appl Biomed 2003; 1:207–11.
14. Marrs TC. Organophosphate poisoning. Pharmacol Ther 1993; 58:51–66. <>
15. Shih T-M. Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats. Arch Toxicol 1993; 67:637–46. <>
16. Ševelová L, Kuča K, Krejčová G, Vachek J. Therapeutic efficacy of oxime treatment in cyclosarin-poisoned mice pretreated with a combination of pyridostigmine, benactyzine and trihexyphenidyle. J Appl Biomed 2004; 2:163–7.
17. Taylor, P. Anticholinesterase agents. In: J.G. Hardman, L.E. Lombird (eds.): The pharmacological basis of therapeutics. New York, McGraw Hill:1996: pp. 161–76.
18. Wang EIC, Braid PE. Oxime reactivation of diethylphosphoryl human serum cholinesterase. J Biol Chem 1967; 242:2683–7.
19. Worek F, Widmann R, Knopff O, Szinicz, L. Reactivating potency of obidoxime, pralidoxime, HI-6 and Hlö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 1998; 72:237–43. <>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal